Free Trial
Doug Schenkel

Doug Schenkel Analyst Performance

Managing Director at UBS Group

Doug Schenkel is a stock analyst at UBS Group in the healthcare sector, covering 23 publicly traded companies. Over the past year, Doug Schenkel has issued 30 stock ratings, including strong buy, buy, and hold recommendations. While full access to Doug Schenkel's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Doug Schenkel's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
49 Last 11 Years
Buy Recommendations
71.74% 33 Buy Ratings
Companies Covered
23 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy2.2%1 ratings
Buy69.6%32 ratings
Hold28.3%12 ratings
Sell0.0%0 ratings

Out of 46 total stock ratings issued by Doug Schenkel at UBS Group, the majority (69.6%) have been Buy recommendations, followed by 28.3% Hold and 2.2% Strong Buy.

Exchange Coverage

ExchangePercentageCount
NASDAQ
47.8% of companies on NASDAQ
11 companies
NYSE
47.8% of companies on NYSE
11 companies
OTCMKTS
4.3% of companies on OTCMKTS
1 company

Doug Schenkel, an analyst at UBS Group, currently covers 23 companies listed on NASDAQ, NYSE and OTCMKTS, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
23 companies
100.0%

Doug Schenkel of UBS Group specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
LIFE SCIENCES TOOLS & SERVICES
15 companies
65.2%
BIOTECHNOLOGY
3 companies
13.0%
HEALTHCARE PROVIDERS & SERVICES
2 companies
8.7%
HEALTHCARE EQUIPMENT & SUPPLIES
2 companies
8.7%
HEALTHCARE TECHNOLOGY
1 company
4.3%

Doug Schenkel's Ratings History at UBS Group

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
11/9/2026Lower Price Target$2.36$2.70Neutral
Veracyte, Inc. stock logo
VCYT
Veracyte
11/9/2026Lower Price Target$25.92$35.00Buy
Caris Life Sciences, Inc. stock logo
CAI
Caris Life Sciences
11/5/2026Set Price Target$33.22$38.00
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
11/4/2026Lower Price Target$13.29$16.00Neutral
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
10/22/2026Reiterated Rating$686.44$800.00Buy
Danaher Corporation stock logo
DHR
Danaher
10/22/2026Reiterated Rating$233.29$260.00Buy
GRAIL, Inc. stock logo
GRAL
GRAIL
10/2/2026Boost Price Target$138.32$175.00Buy
GRAIL, Inc. stock logo
GRAL
GRAIL
9/17/2026Set Price Target$75.11$84.00
Heartflow, Inc. stock logo
HTFL
Heartflow
9/9/2026Initiated Coverage$47.75$55.00Neutral
GRAIL, Inc. stock logo
GRAL
GRAIL
9/9/2026Initiated Coverage$79.10$105.00Buy
Caris Life Sciences, Inc. stock logo
CAI
Caris Life Sciences
9/9/2026Initiated Coverage$24.82$28.00Neutral
Danaher Corporation stock logo
DHR
Danaher
9/9/2026Initiated Coverage$205.23$250.00Buy
Tempus AI, Inc. stock logo
TEM
Tempus AI
9/9/2026Initiated Coverage$64.29$70.00Neutral
Twist Bioscience Corporation stock logo
TWST
Twist Bioscience
9/9/2026Initiated Coverage$128.06$144.00Neutral
Illumina, Inc. stock logo
ILMN
Illumina
9/9/2026Upgrade$211.06$260.00Buy
Waters Corporation stock logo
WAT
Waters
9/9/2026Upgrade$408.52$490.00Buy
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
9/9/2026Boost Price Target$339.55$415.00Buy
Revvity Inc. stock logo
RVTY
Revvity
9/9/2026Initiated Coverage$122.45$140.00Neutral
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
9/9/2026Initiated Coverage$1.31$1.35Neutral
Natera, Inc. stock logo
NTRA
Natera
9/9/2026Boost Price Target$325.80$435.00Buy
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
9/9/2026Initiated Coverage$1,299.83$1,460.00Neutral
Caris Life Sciences, Inc. stock logo
CAI
Caris Life Sciences
9/9/2026Initiated Coverage$24.34$28.00Hold
Danaher Corporation stock logo
DHR
Danaher
9/9/2026Upgrade$200.30Strong-Buy
GRAIL, Inc. stock logo
GRAL
GRAIL
9/9/2026Initiated Coverage$76.23$105.00Buy
Heartflow, Inc. stock logo
HTFL
Heartflow
9/9/2026Initiated Coverage$49.88$55.00Hold
Qiagen N.V. stock logo
QGEN
Qiagen
9/9/2026Lower Price Target$42.39$47.00Hold
Veracyte, Inc. stock logo
VCYT
Veracyte
9/9/2026Boost Price Target$40.87$65.00Buy
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
9/8/2026Upgrade$603.43$730.00Buy
Bruker Corporation stock logo
BRKR
Bruker
12/10/2025Upgrade$45.36$60.00Outperform
Waters Corporation stock logo
WAT
Waters
12/10/2025Upgrade$386.16$480.00Outperform
Guardant Health, Inc. stock logo
GH
Guardant Health
9/25/2025Upgrade$57.67$75.00Outperform